Japan's Ministry Cautions About Personal Import Drugs
This article was originally published in PharmAsia News
Regarding personal imported drugs, Japan's Ministry of Health, Labor and Welfare put out a precautionary notice on its website, warning of the high risk of adverse effects. MHLW stated that the efficiency and safety of personal import drugs have not been confirmed by Japanese Pharmaceutical Affairs Law, and the possibilities of them containing harmful materials exist. Even for drugs that have been approved by overseas regulatory authorities, MHLW warned about possible adverse effects. MHLW further noted that victims of adverse effects caused by personal import drugs are not covered by Japan's relief system for victims of adverse drug reactions. (Click here for more - Japanese language
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.